EMA Endorses Use Of Dexamethasone In COVID-19

The Move Should Speed Up EU National Approvals

Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.

COVID-19 SARS,Coronaviridae , SARS-CoV, SARSCoV, virus 2020 , MERS-CoV ,chinese virus 2019-nCoV
Dexamethasone can be effective in hospitalized COVID-19 patients • Source: Shutterstock

More from Europe

More from Geography